Table 2.
Features of the hospitalized patients due to severe acute respiratory infection (SARI) in Brazil for demographic information, follow-up during the hospitalization, and outcomes during the Coronavirus Disease (COVID)-19 pandemic.
| Patient feature | Category | N (%) |
|---|---|---|
| Sex | Female | 1,245,116 (45.4%) |
| Male | 1,494,416 (54.5%) | |
| Missing data | 740 (0.1%) | |
| Age | <1 y.o. | 61,286 (2.2%) |
| 1–12 y.o. | 114,014 (4.2%) | |
| 13–24 y.o. | 75,076 (2.7%) | |
| 25–60 y.o. | 1,269,398 (46.3%) | |
| 61–72 y.o. | 587,997 (21.5%) | |
| 73–85 y.o. | 440,894 (16.1%) | |
| +85 y.o. | 191,607 (7.0%) | |
| Race | White | 1,105,123 (40.3%) |
| Black | 123,504 (4.5%) | |
| Asian | 26,814 (1.0%) | |
| Individuals from a multiracial background |
957,497 (34.9%) | |
| Indigenous peoples | 5,581 (0.2%) | |
| Missing data | 521,753 (19.0%) | |
| Educational level | Illiterate | 78,718 (2.9%) |
| 1st fundamental cycle | 258,679 (9.4%) | |
| 2nd fundamental cycle | 170,738 (6.2%) | |
| High school | 284,764 (10.4%) | |
| University education | 125,891 (4.6%) | |
| Not applicable | 71,801 (2.6%) | |
| Missing data | 1,749,681 (63.9%) | |
| Place of residence | Urban | 2,271,009 (82.9%) |
| Rural | 126,831 (4.6%) | |
| Peri-urban | 10,052 (0.4%) | |
| Missing data | 332,380 (12.1%) | |
| Living in a Flu outbreak region |
Yes | 261,469 (9.5%) |
| No | 655,385 (23.9%) | |
| Missing data | 1,823,418 (66.5%) | |
| Received Flu vaccine | Yes | 280,660 (10.2%) |
| No | 831,051 (30.3%) | |
| Missing data | 1,628,561 (59.5%) | |
| Used antiviral drug to treat the clinical signs |
Yes | 223,044 (8.1%) |
| No | 1,672,295 (61.0%) | |
| Missing data | 844,933 (30.9%) | |
| Intensive care unit | Yes | 792,754 (28.9%) |
| No | 1,504,205 (54.9%) | |
| Missing data | 443,313 (16.2%) | |
| Mechanical ventilatory support |
Invasive | 420,804 (15.4%) |
| Non-invasive | 1,288,755 (47.0%) | |
| Not required | 562,117 (20.5%) | |
| Missing data | 468,596 (17.1%) | |
| Closure criterion | Laboratorial criterion | 2,230,816 (81.4%) |
| Clinical - Epidemiological | 32,372 (1.2%) | |
| Clinical | 101,384 (3.7%) | |
| Clinical - Image exams | 103,258 (3.8%) | |
| Missing data | 272,442 (9.9%) | |
| Outcome | Cure | 1,577,279 (57.6%) |
| Death | 701,607 (25.6%) | |
| Death not related to SARI | 30,551 (1.1%) | |
| Missing data | 430,835 (15.7%) | |
| SARI categories using the Brazilian Minister of Health definition |
SARI due to Influenza | 3,474 (0.1%) |
| SARI due to other respiratory viruses' infection |
16,627 (0.6%) | |
| SARI due to another known etiological agent |
6,866 (0.3%) | |
| SARI due to an undefined etiological agent |
896,207 (32.7%) | |
| SARI due to COVID-19 (SARS-CoV-2) | 1,817,098 (66.3%) |
We presented the data as the number of individuals (N) and percentage (%).
SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; y.o., years old.